Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Searching for prognostic biomarkers of Parkinson’s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach

View ORCID ProfileCarolina Gonzalez-Riano, Jorge Saiz, Coral Barbas, Alberto Bergareche, José Ma Huerta, Eva Ardanaz, Marcela Konjevod, Elisabet Mondragon, ME Erro, M. Dolores Chirlaque, Eunate Abilleira, Fernando Goñi-Irigoyen, Pilar Amiano
doi: https://doi.org/10.1101/2021.03.02.21252744
Carolina Gonzalez-Riano
1Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28660 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolina Gonzalez-Riano
Jorge Saiz
1Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28660 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Coral Barbas
1Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, 28660 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cbarbas@ceu.es JESUSALBERTO.BERGARECHEYARZA@osakidetza.eus
Alberto Bergareche
2Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastián, Spain
3Disorders Unit, Department of Neurology, University Hospital Donostia, San Sebastián, Spain
4Biomedical Research Networking Centre Consortium for the area of Neurodegenerative Diseases (CIBERNED), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cbarbas@ceu.es JESUSALBERTO.BERGARECHEYARZA@osakidetza.eus
José Ma Huerta
5Instituto Murciano de Investigación Biosanitaria (IMIB)
6CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Ardanaz
6CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
7Instituto de Salud Pública de Navarra, Pamplona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcela Konjevod
8Rudjer Boskovic Institute, Division of Molecular Medicine, Bijenicka cesta 54, 10000 Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabet Mondragon
2Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastián, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ME Erro
9Department of Neurology. Complejo Hospitalario de Navarra, IdiSNA (Navarra Institute for Health Research), Pamplona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Dolores Chirlaque
5Instituto Murciano de Investigación Biosanitaria (IMIB)
6CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eunate Abilleira
10Public Health Laboratory in Gipuzkoa, Biodonostia Health Research Institute, San Sebastián, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Goñi-Irigoyen
6CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
10Public Health Laboratory in Gipuzkoa, Biodonostia Health Research Institute, San Sebastián, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pilar Amiano
6CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
10Public Health Laboratory in Gipuzkoa, Biodonostia Health Research Institute, San Sebastián, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective The lack of knowledge about the onset and progression of Parkinson’s disease (PD) hampers its early diagnosis and treatment. Our aim was to determine the biochemical remodeling induced by PD in a really early and pre-symptomatic stage and unveiling early potential diagnostic biomarkers adopting a multiplatform (LC-MS, GC-MS, CE-MS) untargeted metabolomics approach.

Methods 41,437 healthy volunteers from the European Prospective Study on Nutrition and Cancer (EPIC)-Spain cohort were followed for around 15 years to ascertain incident PD. For this study, baseline pre-clinical plasma samples of 39 randomly selected individuals (46% females, 41– 69 years old) that developed PD (Pre-PD group) and the corresponding control group (n=39, 46% females, 41–69 years old) were analyzed. The metabolic differences were investigated by univariate and multivariate data analyses, followed by pathway-based metabolite analyses to obtain possible clues on biological functions.

Results Our results exposed significantly lower levels of seven free fatty acids in the pre-PD subjects, together with alterations in other metabolite classes. Our finding revealed alterations in fatty acids metabolism, mitochondrial dysfunction, oxidative stress, and gut-brain axis dysregulation.

Conclusions Although the biological purpose of these events is still unknown, the mechanisms involved in the remodelling of the suggested metabolic pathways seem to appear long before the development of PD hallmarks. These findings might be considered as worthy potential markers whose alteration might lead to the development of PD hallmarks in the future. Consequently, this study is of inestimable value since this is the first study conducted with samples collected many years before the disease development.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by grants from the following entities: Basque Government, Spain (GV2016111098), the Spanish Ministry of Science, Innovation and Universities (grant RTI2018-095166-B-I00 to C.B.), and FEDER Program 2014-2020 of the Community of Madrid (S2017/BMD3684).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval and consent to participate: This study was approved by the Ethics Committee for clinical research of the Basque Country PI2017031.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • E-mail addresses: Carolina Gonzalez-Riano: carolina.gonzalezriano{at}ceu.es

    Jorge Saiz: jorge.saizgalindo{at}ceu.es

    Coral Barbas: cbarbas{at}ceu.es

    Alberto Bergareche: JESUSALBERTO.BERGARECHEYARZA{at}osakidetza.eus

    José Mª Huerta: jmhuerta.carm{at}gmail.com

    Eva Ardanaz: mardanaa{at}cfnavarra.es

    Marcela Konjevod: Marcela.Konjevod{at}irb.hr

    Elisabet Mondragon: ELISABET.MONDRAGONREZOLA{at}osakidetza.net

    ME Erro: elena.erro.aguirre{at}cfnavarra.es

    M. Dolores Chirlaque: mdolores.chirlaque{at}carm.es

    Eunate Abilleira: e-abilleira{at}euskadi.eus

    Fernando Goñi-Irigoyen: f-goni{at}euskadi.eus

    Pilar Amiano: epics-san{at}euskadi.eus

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

  • Abbreviations

    BA
    bile acids
    CMPF
    3-carboxy-4-methyl-5-propyl-2-furanpropionic acid
    DPA
    docosapentaenoic acid
    EPIC
    European Prospective Study on Nutrition and Cancer
    FFAs
    free fatty acids
    LPC
    lysoglycerophosphocholines
    MFA
    monounsaturated fatty acid
    MPP+
    1-Methyl-4-phenylpyridinium
    MPTP
    1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    PC
    glycerophosphocholines
    pre-PD
    pre-Parkinson’s Disease development group
    PUFA
    polyunsaturated fatty acid
    QC-SVRC
    quality control samples and support vector regression
    RMT
    relative migration time
    SFA
    saturated fatty acid
    SVM
    Support Vector Machine.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 03, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Searching for prognostic biomarkers of Parkinson’s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Searching for prognostic biomarkers of Parkinson’s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach
    Carolina Gonzalez-Riano, Jorge Saiz, Coral Barbas, Alberto Bergareche, José Ma Huerta, Eva Ardanaz, Marcela Konjevod, Elisabet Mondragon, ME Erro, M. Dolores Chirlaque, Eunate Abilleira, Fernando Goñi-Irigoyen, Pilar Amiano
    medRxiv 2021.03.02.21252744; doi: https://doi.org/10.1101/2021.03.02.21252744
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Searching for prognostic biomarkers of Parkinson’s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach
    Carolina Gonzalez-Riano, Jorge Saiz, Coral Barbas, Alberto Bergareche, José Ma Huerta, Eva Ardanaz, Marcela Konjevod, Elisabet Mondragon, ME Erro, M. Dolores Chirlaque, Eunate Abilleira, Fernando Goñi-Irigoyen, Pilar Amiano
    medRxiv 2021.03.02.21252744; doi: https://doi.org/10.1101/2021.03.02.21252744

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (243)
    • Allergy and Immunology (524)
    • Anesthesia (125)
    • Cardiovascular Medicine (1432)
    • Dentistry and Oral Medicine (219)
    • Dermatology (158)
    • Emergency Medicine (292)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
    • Epidemiology (10325)
    • Forensic Medicine (6)
    • Gastroenterology (533)
    • Genetic and Genomic Medicine (2651)
    • Geriatric Medicine (255)
    • Health Economics (499)
    • Health Informatics (1744)
    • Health Policy (791)
    • Health Systems and Quality Improvement (680)
    • Hematology (269)
    • HIV/AIDS (570)
    • Infectious Diseases (except HIV/AIDS) (12116)
    • Intensive Care and Critical Care Medicine (650)
    • Medical Education (274)
    • Medical Ethics (83)
    • Nephrology (291)
    • Neurology (2478)
    • Nursing (145)
    • Nutrition (381)
    • Obstetrics and Gynecology (496)
    • Occupational and Environmental Health (569)
    • Oncology (1332)
    • Ophthalmology (403)
    • Orthopedics (151)
    • Otolaryngology (239)
    • Pain Medicine (172)
    • Palliative Medicine (51)
    • Pathology (344)
    • Pediatrics (785)
    • Pharmacology and Therapeutics (334)
    • Primary Care Research (296)
    • Psychiatry and Clinical Psychology (2417)
    • Public and Global Health (5029)
    • Radiology and Imaging (900)
    • Rehabilitation Medicine and Physical Therapy (533)
    • Respiratory Medicine (687)
    • Rheumatology (309)
    • Sexual and Reproductive Health (257)
    • Sports Medicine (246)
    • Surgery (300)
    • Toxicology (45)
    • Transplantation (141)
    • Urology (108)